Cummings Maxwell D, Farnum Michael A, Nelen Marina I
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Exton, PA 19341, USA.
J Biomol Screen. 2006 Oct;11(7):854-63. doi: 10.1177/1087057106292746. Epub 2006 Aug 30.
The genomics revolution has unveiled a wealth of poorly characterized proteins. Scientists are often able to produce milligram quantities of proteins for which function is unknown or hypothetical, based only on very distant sequence homology. Broadly applicable tools for functional characterization are essential to the illumination of these orphan proteins. An additional challenge is the direct detection of inhibitors of protein-protein interactions (and allosteric effectors). Both of these research problems are relevant to, among other things, the challenge of finding and validating new protein targets for drug action. Screening collections of small molecules has long been used in the pharmaceutical industry as 1 method of discovering drug leads. Screening in this context typically involves a function-based assay. Given a sufficient quantity of a protein of interest, significant effort may still be required for functional characterization, assay development, and assay configuration for screening. Increasingly, techniques are being reported that facilitate screening for specific ligands for a protein of unknown function. Such techniques also allow for function-independent screening with better characterized proteins. ThermoFluor, a screening instrument based on monitoring ligand effects on temperature-dependent protein unfolding, can be applied when protein function is unknown. This technology has proven useful in the decryption of an essential bacterial enzyme and in the discovery of a series of inhibitors of a cancer-related, protein-protein interaction. The authors review some of the tools relevant to these research problems in drug discovery, and describe our experiences with 2 different proteins.
基因组学革命揭示了大量特征不明的蛋白质。科学家们常常能够仅基于非常远的序列同源性,就生产出毫克级数量的功能未知或为假设性的蛋白质。广泛适用的功能表征工具对于阐明这些孤儿蛋白至关重要。另一个挑战是直接检测蛋白质-蛋白质相互作用的抑制剂(以及变构效应物)。这两个研究问题都与寻找和验证药物作用的新蛋白质靶点等挑战相关。小分子化合物库的筛选长期以来一直被制药行业用作发现药物先导物的一种方法。在这种情况下的筛选通常涉及基于功能的测定。即使有足够数量的目标蛋白质,在功能表征、测定方法开发以及用于筛选的测定配置方面可能仍需要付出巨大努力。越来越多的技术被报道可促进对功能未知蛋白质的特异性配体的筛选。此类技术也允许对特征更明确的蛋白质进行与功能无关的筛选。热荧光技术是一种基于监测配体对温度依赖性蛋白质解折叠的影响的筛选仪器,当蛋白质功能未知时也可应用。这项技术已被证明在解密一种必需的细菌酶以及发现一系列与癌症相关的蛋白质-蛋白质相互作用的抑制剂方面很有用。作者回顾了药物发现中与这些研究问题相关的一些工具,并描述了我们对两种不同蛋白质的研究经验。